Example: Heart Attack

Clinical Trials on Parotitis

Total 32 results

NCT04364399

Recruiting

Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps Vaccine

Conditions: Mumps
NCT04074694

Not yet recruiting

Treatment of Juvenile Recurrent Parotitis: the Yield of Minimally Invasive Intervention

Conditions: Parotitis, Juvenile Recurrent
NCT03133923

Unknown status

Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants

Conditions: Epidemic Parotitis,Mumps
NCT03006627

Unknown status

Gender and Opioid Consumption

Conditions: Postoperative; Parotitis
NCT02901990

Completed

Observational Study to Assess Protection to Mumps in Children Received One-dose Mumps-containing Vaccine

Conditions: Parotid Gland Infection; Fever
NCT02880865

Completed

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

Conditions: Encephalitis, Japanese; Measles; Mumps; Rubella
NCT02692599

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Conditions: Mumps
NCT02184572

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

Conditions: Measles; Mumps; Rubella
NCT02058563

Completed

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

Conditions: Rubella; Mumps; Measles
NCT01991899

Completed

Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.

Conditions: Measles; Mumps; Rubella; Varicella
NCT01874457

Completed

Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)

Conditions: Mumps; Rubella; Measles
NCT01777529

Completed

Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations

Conditions: Measles; Mumps; Rubella
NCT01738841

Withdrawn

Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines

Conditions: Mumps; Rubella; Measles; Varicella
NCT01712906

Completed

A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children

Conditions: The Study Focused on the Safety of Attenuated Mumps Vaccine (Human Diploid Cell) Against Mumps in Chinese Adults, Children and Infants.
NCT01681992

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life

Conditions: Measles; Mumps; Rubella
NCT01621802

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

Conditions: Measles-Mumps-Rubella
NCT01536405

Completed

Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)

Conditions: Measles; Mumps; Rubella; Varicella
NCT01369394

Completed

Making Decisions About the Measles-Mumps-Rubella Vaccine

Conditions: Measles; Mumps; Rubella; MMR Vaccination
NCT01188343

Completed

Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers

Conditions: Japanese Encephalitis; Measles; Mumps; Rubella
NCT00969436

Completed

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

Conditions: Varicella; Rubella; Mumps; Measles
NCT00962819

Completed

Measles, Mumps, and Rubella (MMR) Immunity in College Students

Conditions: Measles; Mumps; Rubella
NCT00861744

Completed

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Conditions: Rubella; Mumps; Measles; Measles-Mumps-Rubella Vaccine
NCT00751348

Completed

Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136

Conditions: Measles; Varicella; Mumps; Rubella
NCT00406211

Completed

Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine

Conditions: Rubella; Varicella; Mumps; Measles
NCT00353288

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

Conditions: Varicella; Rubella; Measles; Mumps
NCT00352898

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

Conditions: Mumps; Rubella; Measles; Varicella
NCT00313950

Completed

Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine

Conditions: Measles; Mumps; Rubella; Hepatitis A
NCT00126997

Completed

Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Conditions: Mumps; Rubella; Measles; Varicella
NCT00127010

Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Conditions: Measles; Rubella; Mumps; Varicella
NCT00127023

Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Conditions: Mumps; Varicella; Rubella; Measles
NCT00092391

Completed

A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)

Conditions: Measles; Mumps; Rubella; Varicella
NCT00092430

Completed

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

Conditions: Measles; Mumps; Rubella; Varicella

COOKIE SETTINGS

Clinical Trials on Parotitis